Here are relevant reports on : OTC-drug

• Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

  • Published: September 2014
  • Price: $ 4950
  • TOC Available:

• AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030

  The global artificial intelligence in precision medicine market, valued at US$0.60B in 2023, is forecasted to grow at a 30.7% CAGR, reaching US$0.78B by 2024 and US$3.92B by 2030. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.

  • Published: November 2024
  • Price: $ 4950
  • TOC Available:

• Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029

  The global gene expression analysis market, valued at US$3.9B in 2023, is forecasted to grow at a 8.1% CAGR, reaching US$4.2B by 2024 and US$6.2B by 2029. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.

  • Published: March 2024
  • Price: $ 4950
  • TOC Available:

• Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029

  The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2029

  The global oral proteins and peptides market, valued at US$6.50B in 2023, is forecasted to grow at a 22.5% CAGR, reaching US$7.38B by 2024 and US$20.36B by 2029. Market growth is attributed to factors such as the increasing prevalence of chronic diseases (such as diabetes and gastroenterology & kidney diseases), advancements in drug delivery technologies, and patient preference & compliance for the oral route of drug administration.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027

  The global Antigen and Antibodies Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing proteomics and genomics research, massive use of antigen and antibodies in the vaccine development, drug discovery, disease study and diagnosis.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Vascular Stent Market by Technology (Drug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029

  The global vascular stents market, valued at US$10.7B in 2023, is forecasted to grow at a 6.5% CAGR, reaching US$11.4B by 2024 and US$15.6B by 2029. The growth of the vascular stents market is primarily attributed to the increasing incidence of vascular diseases (such as coronary artery diseases, peripheral artery diseases, and endovascular aortic aneurysms) and the rising uptake of angioplasty procedures.

  • Published: September 2024
  • Price: $ 4950
  • TOC Available:

• Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022

  The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users - Global Forecasts to 2029

  The global pharmaceutical contract manufacturing market, valued at US$183.6B in 2023, is forecasted to grow at a 9.7% CAGR, reaching US$200.9B by 2024 and US$319.6B by 2029. Increasing use of generic drugs and funding, developments in the field of CMOs technology, the high cost of in-house drug discovery, and regulatory filing by the CMOs drive the growth of this market.

  • Published: August 2024
  • Price: $ 4950
  • TOC Available:

• Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023

  The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

  • Published: January 2019
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50